Location of Repository

Commentary : controversies in NICE guidance on lipid\ud modification for the prevention of cardiovascular disease

By Francesco Cappuccio

Abstract

The new guidelines from the National Institute for Health and Clinical Excellence (NICE) on lipid modification for the prevention of cardiovascular disease will guide the way we assess cardiovascular risk and treat lipids, both in primary and in secondary care. What are the new aspects, and what is it that might spark controversy in this new publication

Topics: R1
Publisher: BMJ Publishing Group Ltd.
Year: 2008
OAI identifier: oai:wrap.warwick.ac.uk:172

Suggested articles

Preview

Citations

  1. 2: Joint British Societies’ guidelines on prevention of cardiovascular disease in clinical practice. doi
  2. 3 LittleP,KellyJ,BarnettJ,DorwardM,MargettsB,WarmD.Randomised controlledfactorialtrialofdietaryadviceforpatientswithasinglehigh blood pressure reading in primary care.
  3. 4 World Health Organization. Reducing salt intake in populations: report of a WHO forum and technical meeting.
  4. 5 Cappuccio FP. Salt and cardiovascular disease. doi
  5. Application of Framingham risk estimates to ethnic minorities in the UK and implications for primary prevention in general practice: a cross sectional population based study. doi
  6. etal.Primarypreventionofcardiovasculardisease:aweb-basedrisk score for seven British black and minority ethnic groups.
  7. (2006). Statins for the prevention of cardiovascular events in patients at increased risk of developing cardiovascular disease and those with established cardiovascular disease.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.